Business Weekly6h
AstraZeneca leads FTSE charge with shares surge and higher dividend
Growing at a rate of knots from the Cambridge Biomedical Campus, AstraZeneca hoisted its market cap to £183.58 billion and ...
Business Weekly7h
Qureight and Avalyn join forces to combat pulmonary fibrosis
A transatlantic Cambridge2Cambridge alliance between Qureight in the UK and Avalyn Pharma Inc in Massachusetts – is seeking ...
Business Weekly7h
Paragraf and University of Cambridge in graphene tech advance
Paragraf, which is pioneering the mass production of graphene-based electronics with standard semiconductor processes, has ...
Business Weekly7h
Onwards, Forwards and Upwards – Biotech and Pharma IP in 2025
As 2025 kicks off there’s lots of activity in the world of IP – particularly in the Biotech and Pharma sectors, writes Marc ...
Business Weekly23h
Nasdaq shares climb as Arm posts record Q3 results and soaring chip demand
Cambridge UK superchip architect Arm saw its stock on the Nasdaq market in the US climb almost seven per cent and $11 to $173 ...